Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Change in Inventory: 2020-2025

Historic Change in Inventory for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to -$9.0 million.

  • Sotera Health's Change in Inventory fell 85.97% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year decrease of 118.57%. This contributed to the annual value of $4.8 million for FY2024, which is 52.34% down from last year.
  • According to the latest figures from Q3 2025, Sotera Health's Change in Inventory is -$9.0 million, which was down 116.48% from -$4.2 million recorded in Q2 2025.
  • Sotera Health's Change in Inventory's 5-year high stood at $16.8 million during Q4 2021, with a 5-year trough of -$9.3 million in Q1 2022.
  • In the last 3 years, Sotera Health's Change in Inventory had a median value of -$1.5 million in 2024 and averaged $1.2 million.
  • Within the past 5 years, the most significant YoY rise in Sotera Health's Change in Inventory was 1,770.83% (2023), while the steepest drop was 2,695.69% (2023).
  • Sotera Health's Change in Inventory (Quarterly) stood at $16.8 million in 2021, then slumped by 103.24% to -$545,000 in 2022, then soared by 1,770.83% to $9.1 million in 2023, then slumped by 116.14% to -$1.5 million in 2024, then slumped by 85.97% to -$9.0 million in 2025.
  • Its last three reported values are -$9.0 million in Q3 2025, -$4.2 million for Q2 2025, and $11.8 million during Q1 2025.